Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Cipla
Johnson and Johnson
US Army
Cerilliant
Queensland Health
UBS
Medtronic
Baxter

Generated: August 17, 2018

DrugPatentWatch Database Preview

DEXEDRINE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Dexedrine, and what generic alternatives are available?

Dexedrine is a drug marketed by Impax Labs Inc and Glaxosmithkline and is included in three NDAs.

The generic ingredient in DEXEDRINE is dextroamphetamine sulfate. There are eighteen drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.

Drug patent expirations by year for DEXEDRINE
Pharmacology for DEXEDRINE
Medical Subject Heading (MeSH) Categories for DEXEDRINE

US Patents and Regulatory Information for DEXEDRINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Labs Inc DEXEDRINE dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 017078-001 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline DEXEDRINE dextroamphetamine sulfate ELIXIR;ORAL 083902-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Impax Labs Inc DEXEDRINE dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 017078-002 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Impax Labs Inc DEXEDRINE dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 017078-003 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline DEXEDRINE dextroamphetamine sulfate TABLET;ORAL 084935-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Covington
Colorcon
Medtronic
AstraZeneca
Federal Trade Commission
Teva
Fish and Richardson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.